Healthcare -
Biotechnology - NASDAQ - US
$ 6.74
2.43 %
$ 686 M
Market Cap
-14.98
P/E
TRVI - COST OF REVENUE
Cost of Revenue TRVI - Trevi Therapeutics, Inc.
0
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR